Trial register facet
Trial records in knee osteoarthritis with obesity
11 records bearing on knee osteoarthritis with obesity.
Showing 0 records on this page
Records
11 documents
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| SURMOUNT-KOA | Tirzepatide | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2025 | Low |
| SURMOUNT-KOA-REGIONAL-JPprogramme record | Tirzepatide | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2025 | Very low |
| SURMOUNT-KOA-BODY-COMPprogramme record | Tirzepatide | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2025 | Very low |
| AOD-OA-PH2 | AOD-9604 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2015 | Low |
| AOD-OA-PH2-PKprogramme record | AOD-9604 | Phase 1 | Reported | Phase 1 ascending dose | — | 2015 | Very low |
| AOD-OA-PH2-RENAL-IMPprogramme record | AOD-9604 | Phase 1 | Reported | Phase 1 ascending dose | — | 2015 | Very low |
| AOD-OA-PH2-HEPATIC-IMPprogramme record | AOD-9604 | Phase 1 | Reported | Phase 1 ascending dose | — | 2015 | Very low |
| AOD-OA-PH2-BODY-COMPprogramme record | AOD-9604 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2015 | Very low |
| TRIUMPH-4 | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Not rated |
| TRIUMPH-4-BODY-COMPprogramme record | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| TRIUMPH-4-REGIONAL-JPprogramme record | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |